These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31934800)

  • 1. Precision medicine and gut dysbiosis.
    Harris C; Kim PT; Waterhouse D; Feng Z; Niergarth J; Lee CH
    Healthc Manage Forum; 2020 May; 33(3):107-110. PubMed ID: 31934800
    [No Abstract]   [Full Text] [Related]  

  • 2. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and engraftment of new bacterial strains by shotgun metagenomic sequence analysis in patients with recurrent Clostridioides difficile infection before and after fecal microbiota transplantation and in healthy human subjects.
    Verma S; Dutta SK; Firnberg E; Phillips L; Vinayek R; Nair PP
    PLoS One; 2021; 16(7):e0251590. PubMed ID: 34252073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbiota transplantation for treatment of patients with recurrent
    Voth E; Khanna S
    Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
    Rao K; Safdar N
    J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pros and cons: Is faecal microbiota transplantation a safe and efficient treatment option for gut dysbiosis?
    Marrs T; Walter J
    Allergy; 2021 Jul; 76(7):2312-2317. PubMed ID: 33483999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection.
    Zuo T; Wong SH; Cheung CP; Lam K; Lui R; Cheung K; Zhang F; Tang W; Ching JYL; Wu JCY; Chan PKS; Sung JJY; Yu J; Chan FKL; Ng SC
    Nat Commun; 2018 Sep; 9(1):3663. PubMed ID: 30202057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiota Therapy With a Focus on Clostridium difficile Infection.
    Brandt LJ
    Psychosom Med; 2017 Oct; 79(8):868-873. PubMed ID: 28976455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
    Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients.
    Nooij S; Ducarmon QR; Laros JFJ; Zwittink RD; Norman JM; Smits WK; Verspaget HW; Keller JJ; Terveer EM; Kuijper EJ;
    Gastroenterology; 2021 Oct; 161(4):1218-1228.e5. PubMed ID: 34126062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal Microbiota Transplantation for the Management of
    Paknikar R; Pekow J
    Surg Infect (Larchmt); 2018; 19(8):785-791. PubMed ID: 30300561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Super-Donor Phenomenon in Fecal Microbiota Transplantation.
    Wilson BC; Vatanen T; Cutfield WS; O'Sullivan JM
    Front Cell Infect Microbiol; 2019; 9():2. PubMed ID: 30719428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway.
    Monaghan T; Mullish BH; Patterson J; Wong GK; Marchesi JR; Xu H; Jilani T; Kao D
    Gut Microbes; 2019; 10(2):142-148. PubMed ID: 30183484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Microbiota Transplantation.
    Vindigni SM; Surawicz CM
    Gastroenterol Clin North Am; 2017 Mar; 46(1):171-185. PubMed ID: 28164849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Fecal Microbiota Transplantation in Recurrent
    Parnell JM; Nicholson MR; Kellermayer R; Kahn SA
    Pediatr Ann; 2021 Dec; 50(12):e515-e521. PubMed ID: 34889135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future trends in clostridioides (clostridium) difficile infection management.
    Khanna S; Gerding DN
    Anaerobe; 2019 Aug; 58():95-102. PubMed ID: 31054313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota.
    Staley C; Vaughn BP; Graiziger CT; Singroy S; Hamilton MJ; Yao D; Chen C; Khoruts A; Sadowsky MJ
    Gut Microbes; 2017 May; 8(3):276-288. PubMed ID: 28282270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Evolving Landscape of Fecal Microbial Transplantation.
    Shao T; Hsu R; Hacein-Bey C; Zhang W; Gao L; Kurth MJ; Zhao H; Shuai Z; Leung PSC
    Clin Rev Allergy Immunol; 2023 Oct; 65(2):101-120. PubMed ID: 36757537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection.
    Jalanka J; Mattila E; Jouhten H; Hartman J; de Vos WM; Arkkila P; Satokari R
    BMC Med; 2016 Oct; 14(1):155. PubMed ID: 27724956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.